Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for renal protection in elective abdominal aortic aneurysm repair
2005-000195-41Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in abdominal aortic aneurysm (AAA), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Urinary N-acetyl-beta-D-glucosaminidase/creatinine ratio. Started May 2005; status: completed.
02
Drugs
methylprednisolone
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2005-000195-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000195-41.